Leukemia and Lymphoma
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 41.7% | 0.861 | Q2 | 79.7% |
| 2024 | 2.2 | Q3 | 49.5% | 0.778 | Q2 | 77.0% |
| 2023 | 2.2 | Q3 | 34.9% | 0.790 | Q2 | 79.4% |
| 2022 | 2.6 | Q3 | 35.7% | 0.837 | Q2 | 81.8% |
| 2021 | 3.0 | Q4 | 42.4% | 0.741 | Q2 | 79.1% |
| 2020 | — | — | 0.961 | Q2 | 84.5% | |
| 2019 | — | — | 0.886 | Q2 | 82.9% | |
| 2018 | — | — | 1.013 | Q2 | 84.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1042-8194
ISSN
1029-2403
country
GBcoverage
1989-2026